ArticleBlood cancer journal2025

Outcomes of CAR T-Cell therapy in relapsed/refractory multiple myeloma by race: a multicenter real-world study.

Manisha Bhutani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.